Auditory event-related potentials in older adults with subjective memory complaints

Document Type

Journal Article

Publication Title

Journal of Alzheimer's disease

Volume

92

Issue

3

First Page

1093

Last Page

1109

PubMed ID

36847006

Publisher

IOS Press

School

School of Medical and Health Sciences

RAS ID

57849

Funders

Australian Government Research Training Program Scholarship at The University of Western Australia / Australian Alzheimer’s Research Foundation / Ear Science Institute Australia

Comments

Tarawneh, H. Y., Jayakody, D. M., Verma, S., Doré, V., Xia, Y., Mulders, W. H., ... & Sohrabi, H. R. (2023). Auditory event-related potentials in older adults with subjective memory complaints. Journal of Alzheimer's Disease, 92(3), 1093-1109. https://doi.org/10.3233/JAD-221119

Abstract

Background: Auditory event-related potentials (AERPs) have been suggested as possible biomarkers for the early diagnosis of Alzheimer's disease (AD). However, no study has investigated AERP measures in individuals with subjective memory complaints (SMCs), who have been suggested to be at a pre-clinical stage of AD. Objective: This study investigated whether AERPs in older adults with SMC can be used to objectively identify those at high risk of developing AD. Methods: AERPs were measured in older adults. Presence of SMC was determined using the Memory Assessment Clinics Questionnaire (MAC-Q). Hearing thresholds using pure-tone audiometry, neuropsychological data, levels of amyloid-β burden and Apolipoprotein E (APOE)ɛ genotype were also obtained A classic two-tone discrimination (oddball) paradigm was used to elicit AERPs (i.e., P50, N100, P200, N200, and P300). Results: Sixty-two individuals (14 male, mean age 71.9±5.2 years) participated in this study, of which, 43 (11 male, mean age 72.4±5.5 years) were SMC and 19 (3 male, mean age 70.8±4.3 years) were non-SMC (controls). P50 latency was weakly but significantly correlated with MAC-Q scores. In addition, P50 latencies were significantly longer in Aβ+ individuals compared to Aβ- individuals. Conclusion: Results suggest that P50 latencies may be a useful tool to identify individuals at higher risk (i.e., participants with high Aβ burden) of developing measurable cognitive decline. Further longitudinal and cross-sectional studies in a larger cohort on SMC individuals are warranted to determine if AERP measures could be of significance for the detection of pre-clinical AD.

DOI

10.3233/JAD-221119

Access Rights

subscription content

Share

 
COinS